InspireMD gets Nasdaq notice for failing $1 minimum bid price rule

InspireMD received a Nasdaq notice on July 17, 2026 for failing the $1 minimum bid price rule, based on June 3–July 16 closes.

Shares keep trading on Nasdaq Capital Market under NSPR; there is no immediate impact on listing status.

The company has until Jan. 13, 2027 to regain compliance by closing at $1 or more for at least 10 consecutive business days.

If it does not cure the deficiency, the company could face delisting risk. A reverse stock split is among the options to restore compliance.